Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats

Acta Histochemica

Volumn 112, Issue 3, 2010, Pages 259-269

  Aksu, Burhan ^a   Umit, Hasan ^a   Kanter, Mehmet ^a   Guzel, Ahmet ^a   Aktas, Cevat ^a   Civelek, Sabiha ^b   Uzun, Hafize ^b  

^a TRAKYA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

smooth muscle actin; Bile duct ligation; Extrahepatic cholestasis; Hepatic fibrosis; Methylene blue; Oxidative stress; Rats

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; HYDROXYPROLINE; MALONALDEHYDE; METHYLENE BLUE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; EXTRAHEPATIC BILE DUCT OBSTRUCTION; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; LEUKOCYTE ACTIVATION; LIVER FIBROSIS; LIVER INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; VASCULAR SMOOTH MUSCLE;

ACTINS; ANIMALS; CHOLESTASIS, EXTRAHEPATIC; COLLAGEN; COMMON BILE DUCT; ENZYME INHIBITORS; INJECTIONS, INTRAPERITONEAL; LIGATION; LIVER; LIVER FUNCTION TESTS; MALE; METHYLENE BLUE; MUSCLE, SMOOTH, VASCULAR; NEUTROPHIL ACTIVATION; OXIDATIVE STRESS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 77950341021     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2008.12.002     Document Type: Article

References (44)

1. Akiyoshi H., Terada T. Mast cell, myofibroblast and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers. J Hepatol 1998, 29:112-119.
2. Aksu B., Inan M., Kanter M., Oz Puyan F., Uzun H., Durmus-Altun G., et al. The effects of methylene blue on renal scarring due to pyelonephritis in rats. Pediatr Nephrol 2007, 22:992-1001.
3. Altman P., Buchmiller T.L. The jaundiced infant: biliary atresia. Pediatric surgery 2006, 1603-1619. Mosby-Year Book. J.L. Grosfeld, J.A. O'Neill, E.W. Fonkalsrud, A.G. Coran (Eds.).
4. Benedetti A., Alvaro D., Bassotti C., Gigliozzi A., Ferretti G., La Rosa T., et al. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. Hepatology 1997, 26:9-21.
5. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 1978, 52:302-310.
6. Cassiman D., Libbrecht L., Desmet V., Denef C., Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002, 36:200-209.
7. Chojkier M., Houglum K., Lee K.S., Buck M. Long and short-term d-a-tocopherol supplementation inhibits liver collagen a1(I) gene expression. Am J Physiol 1998, 275:1480-1485.
8. Chu A.J., Prasad J.K. Up-regulation by human recombinant transforming growth factor beta-1 of collagen production in cultured dermal fibroblasts is mediated by the inhibition of nitric oxide signaling. J Am Coll Surg 1999, 18:271-280.
9. Clemens M.G. Nitric oxide in liver injury. Hepatology 1999, 30:1-5.
10. Cortas N.K., Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990, 36:1440-1443.
11. Cruz A., Padillo F.J., Granados J., Tunez I., Munoz M.C., Briceno J., et al. Effect of melatonin on cholestatic oxidative stress under constant light exposure. Cell Biochem Funct 2003, 21:377-380.
12. Engin A., Bozkurt B., Altan N., Memis L., Bukan N. Nitric oxide-mediated liver injury in the presence of experimental bile duct obstruction. World J Surg 2003, 27:253-255.
13. Farzaneh-Far R., Moore K. Nitric oxide and the liver. Liver 2001, 21:161-174.
14. Fort J., Oberti F., Pilette C., Veal N., Gallois Y., Douay O., et al. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. Hepatology 1998, 28:1525-1531.
15. Galili Y., Ben-Abraham R., Weinbroum A., Klausner J., Rabau M., Kluger Y., et al. Methylene blue prevents pulmonary injury following intestinal ischemia reperfusion. J Trauma 1998, 45:222-225.
16. Gedik N., Kabasakal L., Sehirli O., Ercan F., Sirvanci S., Keyer-Uysal M., et al. Long-term administration of aqueous garlic extract (AGE) alleviates liver fibrosis and oxidative damage induced by biliary obstruction in rats. Life Sci 2005, 76:2593-2606.
17. Guarner C., Soriano G., Tomas A., Bulbena O., Novella M.T., Balanzo J., et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993, 18:1139-1143.
18. Heydrick S.J., Reed K.L., Cohen P.A., Aarons C.B., Gower A.C., Becker J.M., et al. Intraperitoneal administration of methylene blue attenuates oxidative stress, increases peritoneal fibrinolysis, and inhibits intraabdominal adhesion formation. J Surg Res 2007, 143:311-319. [Epub 2007 Sep 10].
19. Houglum K., Brenner D.A., Chojkier M. d-alpha-tocopherol inhibits collagen alpha 1(I) gene expression in cultured human fibroblasts. Modulation of constitutive collagen gene expression by lipid peroxidation. J Clin Invest 1991, 87:2230-2235.
20. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580.
21. Kamat J.P., Devasagayam T.P. Methylene blue plus light induced lipid peroxidation in rat liver microsomes: inhibition by nicotinamide (vitamin B3) and other antioxidants. Chem Biol Interact 1996, 99:1-16.
22. Karaman A., Iraz M., Kirimlioglu H., Karadag N., Tas E., Fadillioglu E. Hepatic damage in biliary-obstructed rats is ameliorated by leflunomide treatment. Pediatr Surg Int 2006, 22:701-708.
23. Kelner M.J., Bagnell R., Hale B., Alexander N.M. Potential of methylene blue to block oxygen radical generation in reperfusion injury. Basic Life Sci 1988, 49:895-898.
24. Kelner M.J., Bagnell R., Hale B., Alexander N.M. Methylene blue competes with paraquat for reduction by flavo-enzymes resulting in decreased superoxide production in the presence of heme proteins. Arch Biochem Biophys 1988, 262:422-426.
25. Kountouras J., Billing B.H., Scheuer P.J. Prolonged bileduct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984, 65:305-311.
26. Liu T.Z., Lee K.T., Chern C.L., Cheng J.T., Stern A., Tsai L.Y. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. Ann Clin Lab Sci 2001, 31:383-390.
27. Marley R., Holt S., Fernando B., Harry D., Anand R., Goodier D., et al. Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis. Hepatology 1999, 29:1358-1363.
28. Mayer B., Brunner F., Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 1993, 45:367-374.
29. Mayoral P., Criado M., Hidalgo F., Flores O., Arévalo M.A., Eleno N., et al. Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation. Clin Sci 1999, 96:297-305.
30. Miyazaki H., Van Eyken P., Roskams T., De Vos R., Desmet V.J. Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study. J Hepatol 1993, 19:353-366.
31. Muriel P. Role of nitric oxide in liver disorders. Liver diseases: biochemical mechanisms and new therapeutic insights 2006, 127-143. Oxford & IBH Publishing, New Delhi. A. Shakir, S.L. Friedman, A.M. Derek (Eds.).
32. Nan J.X., Park E.J., Kim H.J., Ko G., Sohn D.H. Antifibrotic effects of the methanol extract of Polygonum aviculare in fibritic rats induced by bile duct ligation and scission. Biol Pharm Bull 2000, 23:240-243.
33. Ramm G.A., Carr S.C., Bridle K.R., Li L., Britton R.S., Crawford D.H., et al. Morphology of liver repair following cholestatic liver injury: resolution of ductal hyperplasia, matrix deposition and regression of myofibroblasts. Liver 2000, 20:387-396.
34. Roeb E., Purucker E., Gartung C., Geier A., Jansen B., Winograd R., et al. Effect of glutathione depletion and hydrophilic bile acids on hepatic acute phase reaction in rats with extrahepatic cholestasis. Scand J Gastroenterol 2003, 38:878-885.
35. Salaris S.C., Babbs C.F., Voorhees WD I.I.I. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. Biochem Pharmacol 1991, 42:499-506.
36. Sener G., Kabasakal L., Yuksel M., Gedik N., Alican Y. Hepatic fibrosis in biliary-obstructed rats is prevented by Ginkgo biloba treatment. World J Gastroenterol 2005, 11:5444-5449.
37. Sener G., Sehirli A.O., Toklu H.Z., Yuksel M., Ercan F., Gedik N. Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction. Pediatr Surg Int 2007, 23:233-241.
38. Serviddio G., Pereda J., Pallardo F.V., Carretero J., Borras C., Cutrin J., et al. Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology 2004, 39:711-720.
39. Strazzabosco M., Fabris L., Spirli C. Pathophysiology of cholangiopathies. J Clin Gastroenterol 2005, 39:90-102.
40. Sun Y., Oberley L.W., Li Y.A. Simple method for clinical assay of superoxide dismutase. Clin Chem 1988, 34:497-500.
41. Trauner M., Meier P.J., Boyer J.L. Molecular pathogenesis of cholestasis. N Engl J Med 1998, 339:1217-1227.
42. Tuchweber B., Desmoulière A., Bochaton-Piallat M.L., Rubbia-Brandt L., Gabbiani G. Proliferation and phenotypicmodulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 1996, 74:265-278.
43. Wei H., Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis 1993, 14:1195-1201.
44. Woessner J.B. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1961, 93:440-447.